BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma

BMI-1 is overexpressed in a variety of cancers, which can elicit an immune response leading to the induction of autoantibodies. However, BMI-1 autoantibody as a biomarker has seldom been studied with the exception of nasopharyngeal carcinoma. Whether BMI-1 autoantibodies can be used as a biomarker f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yong-Qing, Liu, Bei, Zheng, Hong-Yun, He, Yu-Juan, Gu, Jian, Li, Feng, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221654/
https://www.ncbi.nlm.nih.gov/pubmed/22132147
http://dx.doi.org/10.1371/journal.pone.0027804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221654/
https://www.ncbi.nlm.nih.gov/pubmed/22132147
http://dx.doi.org/10.1371/journal.pone.0027804

Ejemplares similares